Moderna and Merck shares surge after melanoma vaccine success
Moderna shares more than doubled and set an intraday record while Merck climbed more than 10 per cent Wednesday, though questions remain
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Moderna, Merck Revive mRNA Hopes With Melanoma Success bloomberg.com
